Appendix Cancer

Explore clinical trials studying Appendix Cancer. Study availability and eligibility vary by location and protocol.

17 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Appendix Cancer trial results

Active, not recruiting

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

NCT04157322

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +15 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

NCT05623787

Conditions: Abdominal Neoplasms, Appendiceal Neoplasms, Appendix Cancer, +22 more
Locations: CIUSSS de l'Est-de-l'Île-de-Montréal Montreal, Quebec, Canada

CHU de Québec Québec, Quebec, Canada

View Trial Details

Completed

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT04902872

Conditions: Adnexal Diseases, Appendiceal Neoplasms, Appendix Cancer, +61 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

NEXT Oncology Austin, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

NCT04526886

Conditions: Agranulocytosis, Ampullary Cancer, Appendiceal Neoplasms, +31 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Programs To Support You During Chemotherapy

NCT02489422

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +55 more
Locations: Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

NCT02833753

Conditions: Abdominal Neoplasms, Appendiceal Neoplasms, Appendix Cancer, +17 more
Locations: UMass Memorial Medical Center - University Campus Worcester, Massachusetts, United States

View Trial Details

Appendix Cancer

Appendix Cancer trial results

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

The Registry of Oncology Outcomes Associated With Testing and Treatment

Programs To Support You During Chemotherapy

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

Related conditions